Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease

Patients with chronic kidney disease are often insulin resistant and glucose intolerant; abnormalities that promote cardiovascular disease. Administration of 1,25-dihydroxyvitamin D (calcitriol) has improved glucose metabolism in patients with end stage renal disease. We conducted a randomized, plac...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Ian H., Sachs, Michael, Hoofnagle, Andrew N., Utzschneider, Kristina M., Kahn, Steven E., Kestenbaum, Bryan, Himmelfarb, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509239/
https://www.ncbi.nlm.nih.gov/pubmed/22913981
http://dx.doi.org/10.1038/ki.2012.311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509239/
https://www.ncbi.nlm.nih.gov/pubmed/22913981
http://dx.doi.org/10.1038/ki.2012.311

Ejemplares similares